Key Points
➤ The Panel continues to recommend that full, weight-based
cytotoxic chemotherapy doses be used to treat obese adults
with cancer.
➤ The Panel also recommends that full, approved doses of
immunotherapy and targeted therapies be offered to obese
adults with cancer.
➤ In the event of toxicity, the consensus of the Panel is that
dose modifications of systemic antineoplastic therapies
should be handled similarly for obese and non-obese
patients.
